BAJAJ BROKING

Notification
No new Notification messages
Wagons Learning IPO is Open!
Apply for the Wagons Learning IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

2816

500355

RALLIS

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

RALLIS INDIA LTD performance

Today’s low

Today’s high

₹ 234.00 ₹ 244.70
₹ 235.26

52 week low

52 week high

₹ 196.00 ₹ 378.70
₹ 235.26

Open Price

₹ 235.00

Prev. Close

₹ 237.85

Volume (Shares)

391439.00

Total traded value

₹ 920.89

Upper Circuit

₹ 285.42

Lower Circuit

₹ 190.28

info

RALLIS INDIA LTD Share Price Update

As of the latest trading session, RALLIS INDIA LTD share price is currently at ₹ 235.26, which is down by ₹ -2.59 from its previous closing. Today, the stock has fluctuated between ₹ 234.00 and ₹ 244.70. Over the past year, RALLIS INDIA LTD has achieved a return of -11.62 %. In the last month alone, the return has been 6.24 %. Read More...

RALLIS INDIA LTD fundamentals


  • Market cap (Cr)

    4,575.07

  • P/E Ratio (TTM)

    36.57

  • Beta

    1.03

  • Book Value / share

    97.93

  • Return on equity

    8.31%

  • EPS (TTM)

    6.39

  • Dividend yield

    1.04%

  • Net profit/quarter (Cr)

    -32.00

info icon alternate text
  • Market cap (Cr)

    4,601.13

  • P/E Ratio (TTM)

    36.57

  • Beta

    0.99

  • Book Value / share

    97.93

  • Return on equity

    8.31%

  • EPS (TTM)

    6.39

  • Dividend yield

    1.04%

  • Net profit/quarter (Cr)

    -32.00

info icon alternate text

RALLIS INDIA LTD Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2025 (Values in Cr)
Revenue 430.00
Operating Expense 482.00
Net Profit -32.00
Net Profit Margin (%) -7.44
Earnings Per Share (EPS) -1.67
EBITDA -8.00
Effective Tax Rate (%) 20.00
Particulars DEC 2024 (Values in Cr)
Revenue 522.00
Operating Expense 509.00
Net Profit 11.00
Net Profit Margin (%) 2.10
Earnings Per Share (EPS) 0.56
EBITDA 50.00
Effective Tax Rate (%) 42.10
Particulars SEP 2024 (Values in Cr)
Revenue 928.00
Operating Expense 795.00
Net Profit 98.00
Net Profit Margin (%) 10.56
Earnings Per Share (EPS) 5.04
EBITDA 176.00
Effective Tax Rate (%) 31.46
Particulars JUN 2024 (Values in Cr)
Revenue 783.00
Operating Expense 723.00
Net Profit 48.00
Net Profit Margin (%) 6.13
Earnings Per Share (EPS) 2.46
EBITDA 101.00
Effective Tax Rate (%) 26.15
Particulars MAR 2024 (Values in Cr)
Revenue 436.00
Operating Expense 471.00
Net Profit -21.00
Net Profit Margin (%) -4.81
Earnings Per Share (EPS) -1.07
EBITDA 12.00
Effective Tax Rate (%) 27.58
Particulars MAR 2025 (Values in Cr)
Revenue 2663.00
Operating Expense 2509.00
Net Profit 125.00
Net Profit Margin (%) 4.69
Earnings Per Share (EPS) 6.43
EBITDA 319.00
Effective Tax Rate (%) 33.15
Particulars MAR 2024 (Values in Cr)
Revenue 2648.00
Operating Expense 2469.00
Net Profit 148.00
Net Profit Margin (%) 5.58
Earnings Per Share (EPS) 7.61
EBITDA 328.00
Effective Tax Rate (%) 24.48
Particulars MAR 2023 (Values in Cr)
Revenue 2967.00
Operating Expense 2853.00
Net Profit 92.00
Net Profit Margin (%) 3.10
Earnings Per Share (EPS) 4.73
EBITDA 231.00
Effective Tax Rate (%) 28.12
Particulars MAR 2022 (Values in Cr)
Revenue 2603.93
Operating Expense 2408.89
Net Profit 164.27
Net Profit Margin (%) 6.30
Earnings Per Share (EPS) 8.45
EBITDA 301.58
Effective Tax Rate (%) 26.16
Particulars MAR 2021 (Values in Cr)
Revenue 2429.43
Operating Expense 2175.72
Net Profit 228.67
Net Profit Margin (%) 9.41
Earnings Per Share (EPS) 11.76
EBITDA 372.88
Effective Tax Rate (%) 24.68
Particulars MAR 2022 (Values in Cr)
Book Value / Share 87.24
ROE % 9.99
ROCE % 13.01
Total Debt to Total Equity 0.05
EBITDA Margin 11.65
Particulars MAR 2021 (Values in Cr)
Book Value / Share 81.80
ROE % 15.24
ROCE % 19.26
Total Debt to Total Equity 0.06
EBITDA Margin 15.41
Particulars MAR 2020 (Values in Cr)
Book Value / Share 72.48
ROE % 13.63
ROCE % 16.96
Total Debt to Total Equity 0.06
EBITDA Margin 13.71
Particulars MAR 2019 (Values in Cr)
Book Value / Share 66.12
ROE % 12.50
ROCE % 17.40
Total Debt to Total Equity 0.04
EBITDA Margin 13.83
Particulars MAR 2018 (Values in Cr)
Book Value / Share 61.22
ROE % 14.51
ROCE % 19.39
Total Debt to Total Equity 0.03
EBITDA Margin 15.48
Particulars MAR 2024 (Values in Cr)
Book Value / Share 94.06
ROE % 8.31
ROCE % 10.97
Total Debt to Total Equity 0.08
EBITDA Margin 12.41
Particulars MAR 2023 (Values in Cr)
Book Value / Share 88.95
ROE % 5.37
ROCE % 7.59
Total Debt to Total Equity 0.07
EBITDA Margin 7.86
Particulars MAR 2022 (Values in Cr)
Book Value / Share 87.24
ROE % 9.99
ROCE % 13.02
Total Debt to Total Equity 0.05
EBITDA Margin 11.65
Particulars MAR 2021 (Values in Cr)
Book Value / Share 81.83
ROE % 15.24
ROCE % 19.26
Total Debt to Total Equity 0.06
EBITDA Margin 15.41
Particulars MAR 2020 (Values in Cr)
Book Value / Share 72.50
ROE % 13.76
ROCE % 17.08
Total Debt to Total Equity 0.06
EBITDA Margin 13.79
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 63.20
Total Assets 2858.03
Total Liabilities 2858.03
Total Equity 1696.65
Share Outstanding 194468890
Price to Book Ratio 2.73
Return on Assets (%) 5.74
Return on Capital (%) 9.38
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 55.12
Total Assets 2588.61
Total Liabilities 2588.61
Total Equity 1591.48
Share Outstanding 194468890
Price to Book Ratio 3.09
Return on Assets (%) 8.82
Return on Capital (%) 14.03
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 48.65
Total Assets 2448.47
Total Liabilities 2448.47
Total Equity 1410.13
Share Outstanding 194468890
Price to Book Ratio 2.42
Return on Assets (%) 7.54
Return on Capital (%) 12.56
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 45.74
Total Assets 2184.32
Total Liabilities 2184.32
Total Equity 1287.76
Share Outstanding 194468890
Price to Book Ratio 2.50
Return on Assets (%) 7.11
Return on Capital (%) 11.45
Particulars MAR 2018 (Values in Cr)
Cash & Short Term Investments 33.39
Total Assets 1998.59
Total Liabilities 1998.59
Total Equity 1191.67
Share Outstanding 194468890
Price to Book Ratio 3.90
Return on Assets (%) 8.38
Return on Capital (%) 13.83
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 31.51
Total Assets 3003.45
Total Liabilities 3003.45
Total Equity 1829.49
Share Outstanding 194500000
Price to Book Ratio 2.66
Return on Assets (%) 4.92
Return on Capital (%) 8.08
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 46.05
Total Assets 2797.72
Total Liabilities 2797.72
Total Equity 1730.06
Share Outstanding 194500000
Price to Book Ratio 2.17
Return on Assets (%) 3.28
Return on Capital (%) 5.01
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 63.20
Total Assets 2858.03
Total Liabilities 2858.03
Total Equity 1696.65
Share Outstanding 194468890
Price to Book Ratio 2.73
Return on Assets (%) 5.74
Return on Capital (%) 9.36
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 53.90
Total Assets 2587.40
Total Liabilities 2587.40
Total Equity 1591.37
Share Outstanding 194468890
Price to Book Ratio 3.09
Return on Assets (%) 8.83
Return on Capital (%) 14.04
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 47.98
Total Assets 2447.23
Total Liabilities 2447.23
Total Equity 1410.00
Share Outstanding 194468890
Price to Book Ratio 2.42
Return on Assets (%) 7.57
Return on Capital (%) 12.6
Particulars MAR 2022 (Values in Cr)
Net Income 222.41
Cash from Operations 234.57
Cash from Investing -104.19
Cash from Financing -61.44
Net change in Cash 0.26
Free Cash Flow 390.72
Particulars MAR 2021 (Values in Cr)
Net Income 303.50
Cash from Operations 291.28
Cash from Investing -161.54
Cash from Financing -67.41
Net change in Cash -12.17
Free Cash Flow 434.05
Particulars MAR 2020 (Values in Cr)
Net Income 237.49
Cash from Operations 393.20
Cash from Investing -245.91
Cash from Financing -74.41
Net change in Cash 16.50
Free Cash Flow 455.17
Particulars MAR 2019 (Values in Cr)
Net Income 220.26
Cash from Operations 150.95
Cash from Investing -51.44
Cash from Financing -51.49
Net change in Cash -22.88
Free Cash Flow 184.74
Particulars MAR 2018 (Values in Cr)
Net Income 227.02
Cash from Operations 108.88
Cash from Investing 88.79
Cash from Financing -104.14
Net change in Cash 26.04
Free Cash Flow 157.22
Particulars MAR 2024 (Values in Cr)
Net Income 195.66
Cash from Operations 329.17
Cash from Investing -102.27
Cash from Financing -184.31
Net change in Cash -17.51
Free Cash Flow 399.23
Particulars MAR 2023 (Values in Cr)
Net Income 128.07
Cash from Operations 266.27
Cash from Investing -142.11
Cash from Financing -41.04
Net change in Cash 33.67
Free Cash Flow 435.66
Particulars MAR 2022 (Values in Cr)
Net Income 222.48
Cash from Operations 234.05
Cash from Investing -102.92
Cash from Financing -61.44
Net change in Cash 1.48
Free Cash Flow 390.20
Particulars MAR 2021 (Values in Cr)
Net Income 303.59
Cash from Operations 290.80
Cash from Investing -161.55
Cash from Financing -67.42
Net change in Cash -12.73
Free Cash Flow 433.57
Particulars MAR 2020 (Values in Cr)
Net Income 239.26
Cash from Operations 394.35
Cash from Investing -245.92
Cash from Financing -74.41
Net change in Cash 17.65
Free Cash Flow 456.32
Company Name Price P/E P/B Market Cap 52 Week Low/High
EXCEL INDUSTRIES LTD 1060.15 16.75 0.83 1332.68 798.50 / 1745.00
PUNJAB CHEM & CROP PROT L 1111.65 32.48 3.73 1362.88 669.55 / 1575.00
DHANUKA AGRITECH LTD 1299.70 21.12 4.65 5923.81 1091.60 / 1926.40
UPL LIMITED 668.40 0.00 1.86 54403.94 445.64 / 690.95
PI INDUSTRIES LTD 3629.45 32.41 5.76 55065.33 2952.05 / 4801.40
Company Name Price P/E P/B Market Cap 52 Week Low/High
BAYER CROPSCIENCE LTD 4694.30 40.52 6.84 21097.17 4220.05 / 7189.90
EXCEL INDUSTRIES LTD 1060.15 16.78 1.07 1332.68 798.50 / 1745.00
PUNJAB CHEM & CROP PROT L 1111.65 38.31 3.68 1362.88 669.55 / 1575.00
DHANUKA AGRITECH LTD 1299.70 21.12 4.65 5923.81 1091.60 / 1926.40

RALLIS INDIA LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
235.26 -1.08 redarrow
red-green-graph indicator
8 Bearish
8 Bullish
  • 5 Days 237.40
  • 26 Days 229.40
  • 10 Days 235.60
  • 50 Days 231.50
  • 12 Days 234.50
  • 100 Days 247.90
  • 20 Days 230.90
  • 200 Days 265.70
236.79 PIVOT

First Support

233.06

First Resistance

241.57

Second Support

228.28

Second Resistance

245.30

Third Support

224.55

Third Resistance

250.08

RSI

54.28

ADX

26.23

MACD

5.18

Williams % R

-39.08

Commodity Channel Index (CCI)

65.83

Date

2025-04-30

Week

263606.00

Same Day

143209.00

Month

221092.00

1 Year

1.03

3 Year

0.93

Over 1 Month

6.24%

down

Over 1 Year

-11.62%

down

Over 3 Months

-0.35%

down

Over 3 Years

1.28%

down

Over 6 Months

-29.47%

down

Over 5 Years

1.94%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

RALLIS INDIA LTD shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
19.72%
Promoter Holdings
55.08%
FII
11.4%
DII
13.78%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Tata Chemicals Limited 1.0704161E8 (55.04%) Shareholding of Promoter and Promoter Group
Sbi Mutual Fund (various Funds) 1.8333693E7 (9.43%) Public Shareholding
Caisse De Depot Et Placement Du Quebec - First Sentier Investors International Im Limited 4269622.0 (2.2%) Public Shareholding
Fssa Indian Subcontinent Fund As Sub Fund Of First Sentier Investors Global Umbrella Fund Plc 4022216.0 (2.07%) Public Shareholding
Nippon Life India Trustee Ltd-a/c Nippon India Small Cap Fund 2956574.0 (1.52%) Public Shareholding
National Insurance Company Ltd 2136226.0 (1.1%) Public Shareholding
Ewart Investments Limited 75000.0 (0.04%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

RALLIS INDIA LTD corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
06 Jun 2022 3.0 Final 08 Jun 2022 Equity shares
09 Jun 2021 3.0 Final 11 Jun 2021 Equity shares
17 Jun 2020 2.5 Final 19 Jun 2020 Equity shares
19 Jun 2019 2.5 Final 21 Jun 2019 Equity shares
19 Jun 2018 2.5 Final 21 Jun 2018 Equity shares
09 Jun 2017 2.5 Final 13 Jun 2017 Equity shares
09 Jun 2017 1.25 Special 13 Jun 2017 Equity shares
10 Jun 2016 2.5 Final 14 Jun 2016 Equity shares
12 Jun 2015 1.5 Final 16 Jun 2015 Equity shares
29 Oct 2014 1.0 Interim 30 Oct 2014 Equity shares
13 Jun 2014 1.4 Final 17 Jun 2014 Equity shares
30 Oct 2013 1.0 Interim 31 Oct 2013 Equity shares
07 Jun 2013 1.3 Final 11 Jun 2013 Equity shares
29 Oct 2012 1.0 Interim 30 Oct 2012 Equity shares
11 Jun 2012 1.2 Final 13 Jun 2012 Equity shares
01 Nov 2011 1.0 Interim 02 Nov 2011 Equity shares
08 Jun 2011 11.0 Final 10 Jun 2011 Equity shares
28 Oct 2010 9.0 Interim 29 Oct 2010 Equity shares
03 May 2010 10.0 Final 05 May 2010 Equity shares
29 Oct 2009 8.0 Interim 30 Oct 2009 Equity shares
12 May 2009 16.0 Final 14 May 2009 Equity shares
13 May 2008 16.0 Final 15 May 2008 Equity shares
09 May 2007 8.0 Final 11 May 2007 Equity shares
12 May 2006 0.0 Final 16 May 2006 Equity shares
15 Jun 2005 0.0 Final 17 Jun 2005 Equity shares
Ex-Date Ex-Bonus Ratio
09 Jun 2010 08 Jun 2010 1:2
Ex-Date Old FV NEW FV Record Date
15 Jul 2011 10.0 1.0 18 Jul 2011
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
03 Jun 2024 2.5 Final 03 Jun 2024 Equity shares
06 Jun 2022 3.0 Final 08 Jun 2022 Equity shares
09 Jun 2021 3.0 Final 11 Jun 2021 Equity shares
17 Jun 2020 2.5 Final 19 Jun 2020 Equity shares
19 Jun 2019 2.5 Final 21 Jun 2019 Equity shares
19 Jun 2018 2.5 Final 21 Jun 2018 Equity shares
09 Jun 2017 2.5 Final 13 Jun 2017 Equity shares
09 Jun 2017 1.25 Special 13 Jun 2017 Equity shares
10 Jun 2016 2.5 Final 14 Jun 2016 Equity shares
12 Jun 2015 1.5 Final 16 Jun 2015 Equity shares
29 Oct 2014 1.0 Interim 30 Oct 2014 Equity shares
13 Jun 2014 1.4 Final 17 Jun 2014 Equity shares
30 Oct 2013 1.0 Interim 31 Oct 2013 Equity shares
07 Jun 2013 1.3 Final 11 Jun 2013 Equity shares
29 Oct 2012 1.0 Interim 30 Oct 2012 Equity shares
11 Jun 2012 1.2 Final 13 Jun 2012 Equity shares
01 Nov 2011 1.0 Interim 02 Nov 2011 Equity shares
08 Jun 2011 11.0 Final 10 Jun 2011 Equity shares
28 Oct 2010 9.0 Interim 29 Oct 2010 Equity shares
03 May 2010 10.0 Final 05 May 2010 Equity shares
29 Oct 2009 8.0 Interim 30 Oct 2009 Equity shares
12 May 2009 16.0 Final 14 May 2009 Equity shares
13 May 2008 16.0 Final 15 May 2008 Equity shares
09 May 2007 8.0 Final 11 May 2007 Equity shares
12 May 2006 0.0 Final 16 May 2006 Equity shares
15 Jun 2005 0.0 Final 17 Jun 2005 Equity shares
Ex-Date Ex-Bonus Ratio
09 Jun 2010 08 Jun 2010 1:2
Ex-Date Old FV NEW FV Record Date
15 Jul 2011 10.0 1.0 18 Jul 2011

RALLIS INDIA LTD Share Price

Rallis India Limited is a leading player in the agricultural inputs industry. Being as Tata Enterprise since 1964, the Company is a leading crop inputs company with presence across the agricultural input value chain. It markets products for each step of crop cycle to facilitate an integrated crop management system and increase agricultural yield and farm income. It has a diversified portfolio and a channel network of 4,500 dealers and 60,000 retailers.

Rallis India Limited was incorporated on August 23, 1948. The Company is engaged research, development, manufacturing and distribution of Crop Protection and Crop Nutrition solutions. It provide safe and sustainable products in Crop Protection, Crop Nutrition and Seeds. Its Crop Protection portfolio of Active Ingredients, bulk and branded formulations covers fungicides, herbicides and insecticides and caters to domestic and international markets. Besides, the Crop Nutrition portfolio, focused in domestic market, consists of biostimulants, biofertilisers, biopesticides, organic fertilisers, water soluble fertilisers as well as micro and secondary nutrients.

Its Agribusiness division is the distributor of Pesticides, fertilisers, micronutrients, seeds, animal feed and other agro inputs. It has 4 production facilities, of which, 2 are located in Gujarat (at Ankleshwar and Dahej) and 2 in Maharashtra (at Lote and Akola).

The company discontinued marketing of Monsanto seeds during the year 2001-02. The company commenced production of a range of ethylene oxide condensates based surfactants, which found captive use in its agrochemical formulations during 1999-2000. This helped the company to reduce the cost. During 2000-2001, the company established seed processing facilities at Dhar (MP) and Patancheru, near Hyderabad and research infrastructure, quality control and storage facility at Patancheru.

The Rallis Agro Research Centre, based in Bangalore, leads in toxicology and entomology research. Its facilities and research practices (GLP) are recognised by Bundesgesundheitsammt (BGA), Germany.

The Fine Chemicals division of the company operates two factories both in Tamilnadu at Ootacamund and Cuddalore. The company has suspended the manufacturing activity at Cuddalore plant as the third party manufacturing offers a cheaper alternative. Rallis is the leading producer and distributor of agro-based tanning materials from a variety of forest products. During 2004, the company sold out its Gelatin business of the Fine Chemicals Division to Sterling Biotech Ltd.

Rallis is undertaking restructuring of its business, which includes consolidation, merger and selloff. First step in this regard was taken by Rallis is merger of its 5 subsidiaries viz Ralchem Ltd,Rallis Finance & Investments Co Ltd, Rallis Hybrid Seeds Ltd, Rallis Farm Management Services Ltd and Sankhya Garments Ltd with itself. The petitions has been filed and the company awaiting final hearing by the court. It has also filed a petition for merging sixth subsidiary viz. Siris India Ltd with itself. During 2003-04, the Company received the approval from the court for the merger of six subsidiaries with itself.

The Pharmaceutical business of Rallis, which engaged in marketing of household remedies and manufacturing of basic drugs was sold to Shreya Life Sciences Pvt Ltd. a member of Russia based pharma marketing and distribution company for Rs.49 Crore. And the transfer of business is completed effective June 30, 2001. The company has also completed the sale of its Andheri property to Orchid Print India Ltd., a wholly owned subsidiary of Tata Sons Ltd during the year 2001-02.

Rallis has discontinued the distribution of bulk fertilizers and the arrangement with Tata Chemicals came to an end from 1st March 2003. It is also shifting its focus from a seeds distributor to become a sourcing and branding company with focussed R&D.

During 2005, the company transferred its Knowledge Services Business which includes the Research & Development Centre at Bangalore,as a going concern to Advinus Therapeutics Pvt Ltd with effect from 1st April 2005 for a consideration of Rs.26 Crores.

In the year 2005, the company increased its installed capacity of Pesticides (Solids) by 920 Tonnes. With this expansion, the total installed capacity of Pesticides (Solids) has increased upto 22825 Tonnes.

In 2006, the company has been established new Development Center at Patancheru. All Research and development, including NMITLI and NPDL, is being carried out at this new location. All the regulatory studies required for obtaining the registrations are being outsoured through Advinus Therapeutics Pvt Ltd and other government and private institutions.

The company has started the sourcing and markeitng of Bt Cotton Seeds. An Alliance with Nuziveedu Seed Company, a Major Player in hybrid and Bt Cotton seed market, has been estahlished for purposes.

In 2007, The company has incorporated a subsidiary in Australia viz. Rallis Australasia Pty Ltd., in order to enhance its presence in Australia.The company has successfully launched three new products in the year viz. Nova, Applaud and Taqat. Applaud has been a great success in the year, wherein the company gained a phenomenal response from paddy growers.

The first year of Bt cottonseed marketing has been rewarding and valuable experience gained, which will support expansion of this activity in the coming year. Preparation to expand into marketing of seeds in the rice and vegetable markets has been initiated.

During the year 2014, Rallis India acquired additional stake of equity shares in Zero Waste Agro Organics Limited (ZWAOL), a subsidiary company of Rallis India pursuant to the Share Subscription and Share Purchase Agreement dated 23rd April 2012. Consequently, the shareholding of the Company in ZWAOL has increased from 22.81% to 51.02%. During the year, the Company has also acquired additional stake of equity shares in Metahelix Life Sciences Ltd. (Metahelix), pursuant to the Share Purchase Agreement dated 9 December 2010. Consequently, the shareholding of the Company in Metahelix has increased from 77.02% to 80.5%.

During FY 2016, the Company acquired the balance equity shares in Metahelix Life Sciences Ltd. (Metahelix). Consequently, the shareholding of the Company in Metahelix has increased from 80.51% to 100%, making Metahelix a wholly owned subsidiary of the Company. The company has made an investment of Rs 73.33 crores for acquiring an additional 20,953 Equity Shares of Metahelix.

In FY16, the Company signed an Agreement with Ikea India Pvt. Ltd., for assignment of its leasehold rights in respect of its leasehold land at Turbhe, Navi Mumbai, for a gross consideration of Rs 214 crores. The arrangement is subject to the Company obtaining necessary approvals under various regulations.

During the year 2016, the Company's Board approved granting of a Corporate Guarantee in respect of credit facilities of up to Rs 270 crores availed by Advinus Therapeutics Ltd. (Advinus), to the extent of 16.89% of the total obligations of Advinus under such borrowings. The Guarantee has been issued during the first week of April 2016.

During FY 2017, Metahelix has invested USD 1,22,500 for 1,22,500 Equity shares of USD 1 each, with 65.77% shareholding in an Indonesian Joint Venture (JV). Mr. Suresh Vaswani, the JV partner has invested his share of USD 1,27,500 for 63,750 Equity Shares of USD 2 each, with 34.23% shareholding. The JV Company PT Metahelix Lifesciences Indonesia, has initiated seed production operations in March 2017. Testing and evaluation of new products in Maize and Rice in Indonesia shall be initiated during 2017-18.

During the year 2017, the Company has acquired the balance Equity Shares in Zero Waste Agro Organics Ltd. (ZWAOL). Consequently, the shareholding of the Company in ZWAOL has increased from 73.63% to 100%, making it a wholly owned subsidiary of the Company. The Company has made an investment of Rs. 19.49 crores for acquiring an additional 19,421 Equity Shares of ZWAOL.

During the year 2018, Metahelix has invested USD 183,750 for 183,750 Equity shares of USD 1 each with 65.77% shareholding in its Indonesian Joint Venture (JV) Company PT Metahelix Lifesciences Indonesia (PT Metahelix) as per the commitment in the JV Agreement. The JV partner has also invested his share of USD 191,250 for 95,625 Equity Shares of USD 2 each with 34.23% shareholding. The total equity of PT Metahelix stands at USD 625,000 as on 31 March 2018.

In FY 2017-18, the Company received four registrations for the domestic market (two each for domestic and export category) and 12 registrations for the international market. Moreover, the Company has completed field trials of three more products and is ready for the registration process.

During year under review, the Company has gained 11 new registrations in strategic overseas markets. Partnership models with strategic customers that were adopted during the year helped the Company in its growth journey through leveraging each other's strengths. IBD continues its focus on developmental activities in key geographies in Latin America, South East Asia, Europe and African markets.

During the year under review, 3 Blocks (Afzalpur, Bijapur and Bhalki) from 3 Districts (Gulbarga, Bijapur and Bidar) in Karnataka were covered under PPP IAD Project with Karnataka Government for Pulses Productivity improvement for Red Gram (Pigeon Pea) and Bengal Gram (Chick Pea), which are saviour crops for farmers apart from major crops in that area. Increase in productivity and quality helps farmers for additional income generation and fetching better prices for their produce.

During the year 2019, the Board of Directors of the Company approved the proposal for the merger of Metahelix, a wholly owned subsidiary of the Company, with the Company and their shareholders and creditors pursuant to Sections 230 to 232 of the Act and as per the terms and conditions mentioned in the Scheme of Amalgamation. The merger is subject to the necessary approvals/ sanctions from the jurisdictional National Company Law Tribunal or such other competent authority and shareholders and creditors of Metahelix and the Company, as applicable.

During the year 2019, the Company has made an investment of Rs 19.60 lakhs in Rallis Chemistry Exports Limited, wholly owned subsidiary of the Company, by way of equity shares.

The NCLT, Mumbai Bench had sanctioned the Scheme of Arrangement in FY 2019-20, where Zero Waste Agro-Organics Limited (ZWAOL), a wholly owned subsidiary was merged with the Company and ceased to be a subsidiary effective from July 9, 2020.

In FY 2021, Company launched 4 new products in Crop Protection (including 3 in-house formulations) and 6 new products in Crop
Nutrition (including 2 in Biopesticides). It increased the number of dealers by 5% and retailers by 17%. It continued up-stocking of raw materials to avert production disruptions due to potential supply chain issues and price hike. It acquired 9 new registrations internationally. It attained global leadership in most Active Ingredients manufactured. It invested in research, registration and manufacturing to expand portfolio. It added 2 new manufacturing plants at Dahej, to strengthen capabilities across business segments. It launched and promoted 2 botanical biopesticides through strategic partnerships.

The Company gained 17 new registrations in the overseas market in FY 2022. Infrastructure and people skill-sets were augmented at the Bengaluru R&D centre and chemistry platforms were expanded. The herbicide Active Ingredient capacities at Dahej were enhanced to service the International business. It launched 6 new products such as, Aquafert Cotton, Aquafert Apple, Ralli Derma, Ralli Flomonas, Ralli Pecilo and GeoGain K+. It strengthened presence in Soybean and Paddy crops with newly-launched Prodim, PePe and Preet Plus. In addition, the Herbicides portfolio gained market share in crops such as Paddy, Soybean and Pulses. Research and Development activities were intensified and more than 20 products covering multiple segments across categories were chosen for commercialisation. PT Metahelix Lifesciences Indonesia ceased to be a subsidiary of the Company effective from March 23, 2022.

During the year 2022-23, the Company launched Clasto for Cotton white fly, which is also the carrier of dreaded cotton leaf curl virus. The Paddy portfolio further strengthened with the launch of Clue for brown plant hopper menace and Dext for borer segment. It launched Onto for control of sucking pests in tea and also having wider application in multiple crops. It launched Zaafu and Ayaan; launched Daksh Plus, a highly differentiated wheat herbicide during Rabi 2022.

Parent organization Tata
NSE symbol RALLIS
Founded 1948
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Rallis India Ltd?

Answer Field

The share price of Rallis India Ltd for NSE is ₹ 235.26 and for BSE is ₹ 236.6.

What is the Market Cap of Rallis India Ltd?

Answer Field

The market cap of Rallis India Ltd for NSE is ₹ 45,75.07 Cr. and for BSE is ₹ 46,01.13 Cr. as of now.

What is the 52 Week High and Low of Rallis India Ltd?

Answer Field

The 52 Week High and Low of Rallis India Ltd for NSE is ₹ 378.70 and ₹ 196.00 and for BSE is ₹ 378.40 and ₹ 196.00.

How to Buy Rallis India Ltd share?

Answer Field

You can trade in Rallis India Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Rallis India Ltd?

Answer Field

The 1 year returns on the stock has been -11.62%.

What is the Current Share Price of Rallis India Ltd?

Answer Field

Rallis India Ltd share price is for NSE ₹ 235.26 & for BSE ₹ 236.6 as on Apr 30 2025 03:30 PM.

What is the Market Cap of Rallis India Ltd Share?

Answer Field

The market cap of Rallis India Ltd for NSE ₹ 45,75.07 & for BSE ₹ 46,01.13 as on Apr 30 2025 03:30 PM.

What is the P/E Ratio of Rallis India Ltd Share?

Answer Field

As on Apr 30 2025 03:30 PM the price-to-earnings (PE) ratio for Rallis India Ltd share is 36.57.

What is the PB ratio of Rallis India Ltd Share?

Answer Field

As on Apr 30 2025 03:30 PM, the price-to-book (PB) ratio for Rallis India Ltd share is 97.93.

How to Buy Rallis India Ltd Share?

Answer Field

You can trade in Rallis India Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Rallis India Ltd Share on Bajaj Broking App?

Answer Field

To buy Rallis India Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Rallis India Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|